A look at SpringWorks Therapeutics Inc’s (SWTX) recent performance gives investors their first glimpse of hope.

On Tuesday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) opened higher 4.97% from the last session, before settling in for the closing price of $34.63. Price fluctuations for SWTX have ranged from $28.21 to $53.92 over the past 52 weeks.

Healthcare Sector giant saw their annual sales slid by -25.00% over the last five years. Company’s average yearly earnings per share was noted 39.49% at the time writing. With a float of $65.76 million, this company’s outstanding shares have now reached $74.34 million.

The firm has a total of 305 workers. Let’s measure their productivity. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.

SpringWorks Therapeutics Inc (SWTX) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SpringWorks Therapeutics Inc is 11.59%, while institutional ownership is 101.73%. The most recent insider transaction that took place on Dec 03 ’24, was worth 839,336. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $41.97, taking the stock ownership to the 209,600 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Executive Officer sold 49,000 for $41.37, making the entire transaction worth $2,027,357. This insider now owns 1,014,368 shares in total.

SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 39.49% per share during the next fiscal year.

SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators

Check out the current performance indicators for SpringWorks Therapeutics Inc (SWTX). In the past quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.96.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.12 in one year’s time.

Technical Analysis of SpringWorks Therapeutics Inc (SWTX)

Analysing the last 5-days average volume posted by the [SpringWorks Therapeutics Inc, SWTX], we can find that recorded value of 1.67 million was lower than the volume posted last year of 2.05 million. As of the previous 9 days, the stock’s Stochastic %D was 23.72%. Additionally, its Average True Range was 3.01.

During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 46.67%, which indicates a significant increase from 32.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.19% in the past 14 days, which was higher than the 55.96% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $37.67, while its 200-day Moving Average is $37.93. Now, the first resistance to watch is $37.75. This is followed by the second major resistance level at $39.15. The third major resistance level sits at $40.72. If the price goes on to break the first support level at $34.79, it is likely to go to the next support level at $33.22. Should the price break the second support level, the third support level stands at $31.82.

SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats

There are currently 74,386K shares outstanding in the company with a market cap of 2.70 billion. Presently, the company’s annual sales total 5,450 K according to its annual income of -325,100 K. Last quarter, the company’s sales amounted to 49,300 K and its income totaled -53,530 K.